Archive: September, 2014

 

 

Nexvet – Two industry leaders join the Board of Directors

Veterinary biologic therapy developer Nexvet Biopharma today announced the appointments of Dr. Ashraf Hanna, M.D., Ph.D., and Dr. Joseph McCracken D.V.M., M.S., to its Board of Directors. Dr. Hanna is the Vice President of Commercial and Medical Affairs Finance at Genentech and Chief Financial Officer for the Genentech Foundation, while Dr. McCracken most recently served as Vice President and Global Head of Business Development and Licensing for Roche Pharma.

Read more about Nexvet – Two industry leaders join the Board of Directors

Nexvet expands veterinary biologics research team

Nexvet Biopharma has added two former CSL (ASX:CSL) scientists to its veterinary biologics research team.

Read more about Nexvet expands veterinary biologics research team